R-form lipopolysaccharides (LPS) of gram-negative bacteria as possible vaccine antigens

FEMS Immunology and Medical Microbiology

Volumn 18, Issue 3, 1997, Pages 139-145

  Stanislavsky, Eugene S ^a   Makarenko, Tatyana A ^a   Kholodkova, Elena V ^a   Lugowski, Czeslaw ^b  

^a MECHNIKOV RESEARCH INSTITUTE FOR VACCINES AND SERA   (Russian Federation)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Escherichia coli; Lipopolysaccharide; Pseudomonas aeruginosa; R mutant; Salmonella minnesota; Shigella; Vaccine

Indexed keywords

BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA; SHIGELLA;

AGGLUTINATION; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIA; LIPOPOLYSACCHARIDES; MALE; MICE; MUTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS; SALMONELLA; SHIGELLA;

EID: 0030748882     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(97)00033-3     Document Type: Article

References (22)

1. Stanislavsky, E.S. (1996) Letter to Editor. Vaccine 14, 179.
2. Stanislavsky, E.S., Makarenko, T.A. and Kozhenova, T.E. (1992) Specific and non-specific mouse protection induced by different chemotypes of the Pseudomonas aeruginosa lipopolysaccharides. FEMS Microbiol. Immunol. 105, 181-190.
3. Kievide, T.R. and Lam, J.S. (1994) Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide. J. Bacteriol. 176, 7129-7139.
4. Yokota, S.-I., Ochi, H., Ohtsuka, H. et al. (1989) Heterogeneity of the L-rhamnose residue in the outer core of Pseudomonas aeruginosa lipopolysaccharide, characterized by using human monoclonal antibodies. Infect. Immun. 57, 1691-1696.
5. Terashima, M., Uezuma, K., Tomio, T. et al. (1991) Protective human monoclonal antibodies directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide. Infect. Immun. 59, 1-6.
6. Lugowski, C., Jachymek, W. and Niedziela, T. (1994) Protective anti-core type R1-tetanus toxoid conjugate serum binds to smooth lipopolysaccharides and smooth, a live bacterial cells. Abstracts of the Third Conference of the International Endotoxin Society, August 15-18. J. Endotoxin Res. C187, 90.
7. Stanislavsky, E.S., Kholodkova, E.V., Makarenko, T.A. and Sukhachevskaya, M.V. (1995) Mouse protection induced by Pseudomonas aeruginosa PAC1R and its defective mutants, Salmonella minnesota Re-mutant and Escherichia coli O14. FEMS Immunol. Med. Microbiol. 11, 81-86.
8. Row, P.S.N. and Meadow, P. (1983) Structure of the core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants. Eur. J. Biochem. 132, 329-337.
9. Stanislavsky, E.S., Dmitriev, B.A., Lányi, B. and Joo, I. (1985) Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy. A review. Acta Microbiol. Hung. 32, 3-37.
10. Lugowski, C., Kulakowska, M. and Romanowska, E. (1986) Characterization and diagnostic application of a lipopolysaccharide core oligosaccharide-protein conjugate. J. Immunol. Methods 95, 187-194.
11. Westphal, O. and Jann, K. (1965) Bacterial lipopolysaccharides. Extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem. 5, 83-91.
12. Galanos, C., Luderitz, O. and Westphal, O. (1968) A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9, 245-249.
13. Stanislavsky, E.S., Edvabnaya, L.S., Bandman, O.A. et al. (1989) Experimental studies on the protective efficacy of a Pseudomonas aeruginosa vaccine. Vaccine 7, 562-566.
14. Homma, J.Y. (1976) A new antigenic schema and live cell slide agglutination procedure for the intrasubspecific, serologic, classification of Pseudomonas aeruginosa. A review. Jpn. J. Exp. Med. 46, 329-336.
15. Van der Warden, B.L. (1957) Mathematische Statistik. Springer Verlag, Berlin.
16. Penketh, A., Pitt, T., Roberts, D. et al. (1993) The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am. Rev. Respir. Dis. 127, 605-608.
17. Lam, M.Y.C., Mcgroarty, E.J., Kropinski, A.M. et al. (1989) Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa. J. Clin. Microbiol. 27, 962-967.
18. MacCabe, W.R. (1972) Immunization with R-mutants of Salmonella minnesota. 1. Protection against challenge with heterologous Gram-negative bacilli. J. Immunol. 108, 601-610.
19. MacCabe, W.R., Bruins, S.C., Craven, D.E. et al. (1977) Cross-reactive antigens: their potential for immunization induced immunity to Gram-negative bacteria. J. Infect. Dis. 136, Suppl. S161-S166.
20. Di Padova, F.E., Brade, H., Bardy, G.R. et al. (1993) A broad cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect. Immun. 61, 3863-3872.
21. Dunn, D.L., Bogard, W.C. and Cerra, F.B. (1995) Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. Surgery 98, 283-290.
22. Pollack, M., Chia, J.K.S., Koles, N.L. et al. (1989) Specific and cross-reactivity of monoclonal antibodies reactive with the core and lipid A region of bacterial lipopolysaccharides. J. Infect. Dis. 159, 168-188.